Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12(2):61–76. https://doi.org/10.1097/GIM.0b013e3181cd68ed
Article
CAS
PubMed
Google Scholar
Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chretien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chretien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch P (2010) Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 467(7313):318–322. https://doi.org/10.1038/nature09328
Article
CAS
PubMed
PubMed Central
Google Scholar
Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, Hongeng S, Hacein-Bey S, Cavazzana M, Leboulch P, Payen E (2016) Gene therapy of the beta-hemoglobinopathies by lentiviral transfer of the beta(a(T87Q))-globin gene. Hum Gene Ther 27(2):148–165. https://doi.org/10.1089/hum.2016.007
Article
CAS
PubMed
PubMed Central
Google Scholar
Ronen K, Negre O, Roth S, Colomb C, Malani N, Denaro M, Brady T, Fusil F, Gillet-Legrand B, Hehir K, Beuzard Y, Leboulch P, Down JD, Payen E, Bushman FD (2011) Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat beta-thalassemia. Mol Ther 19(7):1273–1286. https://doi.org/10.1038/mt.2011.20
Article
CAS
PubMed
PubMed Central
Google Scholar
Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, Modlich U, Beier R, Gohring G, Steinemann D, Fronza R, Ball CR, Haemmerle R, Naundorf S, Kuhlcke K, Rose M, Fraser C, Mathias L, Ferrari R, Abboud MR, Al-Herz W, Kondratenko I, Marodi L, Glimm H, Schlegelberger B, Schambach A, Albert MH, Schmidt M, von Kalle C, Klein C (2014) Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med 6(227):227ra233. https://doi.org/10.1126/scitranslmed.3007280
Article
CAS
Google Scholar
Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302(5644):415–419. https://doi.org/10.1126/science.1088547
Article
CAS
PubMed
Google Scholar
Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kuhlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Luthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12(4):401–409. https://doi.org/10.1038/nm1393
Article
CAS
PubMed
Google Scholar
Woods NB, Bottero V, Schmidt M, von Kalle C, Verma IM (2006) Gene therapy: therapeutic gene causing lymphoma. Nature 440(7088):1123. https://doi.org/10.1038/4401123a
Article
CAS
PubMed
Google Scholar
Steyer B, Bu Q, Cory E, Jiang K, Duong S, Sinha D, Steltzer S, Gamm D, Chang Q, Saha K (2018) Scarless genome editing of human pluripotent stem cells via transient puromycin selection. Stem Cell Rep. https://doi.org/10.1016/j.stemcr.2017.12.004
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu P, Tong Y, Liu XZ, Wang TT, Cheng L, Wang BY, Lv X, Huang Y, Liu DP (2015) Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in beta-thalassemia-derived iPSCs. Sci Rep 5:12065. https://doi.org/10.1038/srep12065
Article
PubMed
PubMed Central
Google Scholar
Cai L, Bai H, Mahairaki V, Gao Y, He C, Wen Y, Jin YC, Wang Y, Pan RL, Qasba A, Ye Z, Cheng L (2018) A universal approach to correct various HBB gene mutations in human stem cells for gene therapy of beta-thalassemia and sickle cell disease. Stem Cells Transl Med 7(1):87–97. https://doi.org/10.1002/sctm.17-0066
Article
CAS
PubMed
Google Scholar
Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, Pavel-Dinu M, Saxena N, Wilkens AB, Mantri S, Uchida N, Hendel A, Narla A, Majeti R, Weinberg KI, Porteus MH (2016) CRISPR/Cas9 beta-globin gene targeting in human haematopoietic stem cells. Nature 539(7629):384–389. https://doi.org/10.1038/nature20134
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang X, Wang Y, Yan W, Smith C, Ye Z, Wang J, Gao Y, Mendelsohn L, Cheng L (2015) Production of gene-corrected adult Beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation. Stem Cells 33(5):1470–1479. https://doi.org/10.1002/stem.1969
Article
CAS
PubMed
PubMed Central
Google Scholar
Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, Lv J, Xie X, Chen Y, Li Y, Sun Y, Bai Y, Songyang Z, Ma W, Zhou C, Huang J (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6(5):363–372. https://doi.org/10.1007/s13238-015-0153-5
Article
CAS
PubMed
PubMed Central
Google Scholar
Niu X, He W, Song B, Ou Z, Fan D, Chen Y, Fan Y, Sun X (2016) Combining single strand oligodeoxynucleotides and CRISPR/Cas9 to correct gene mutations in beta-thalassemia-induced pluripotent stem cells. J Biol Chem 291(32):16576–16585. https://doi.org/10.1074/jbc.M116.719237
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang L, Zeng Y, Du H, Gong M, Peng J, Zhang B, Lei M, Zhao F, Wang W, Li X, Liu J (2017) CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein. Mol Gen Genomics 292(3):525–533. https://doi.org/10.1007/s00438-017-1299-z
Article
CAS
Google Scholar
Thein SL (2013) The molecular basis of beta-thalassemia. Cold Spring Harb Perspect Med 3(5):a011700. https://doi.org/10.1101/cshperspect.a011700
Article
CAS
PubMed
PubMed Central
Google Scholar
Richardson CD, Ray GJ, DeWitt MA, Curie GL, Corn JE (2016) Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat Biotechnol 34(3):339–344. https://doi.org/10.1038/nbt.3481
Article
CAS
PubMed
Google Scholar
Antony JS, Dewerth A, Haque A, Handgretinger R, Kormann MS (2015) Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies. Mol Cell Pediatr 2(1):11. https://doi.org/10.1186/s40348-015-0022-6
Article
PubMed
PubMed Central
Google Scholar
Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB, Bacchetta R, Tsalenko A, Dellinger D, Bruhn L, Porteus MH (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33(9):985–989. https://doi.org/10.1038/nbt.3290
Article
CAS
PubMed
PubMed Central
Google Scholar
Mahiny AJ, Dewerth A, Mays LE, Alkhaled M, Mothes B, Malaeksefat E, Loretz B, Rottenberger J, Brosch DM, Reautschnig P, Surapolchai P, Zeyer F, Schams A, Carevic M, Bakele M, Griese M, Schwab M, Nurnberg B, Beer-Hammer S, Handgretinger R, Hartl D, Lehr CM, Kormann MS (2015) In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency. Nat Biotechnol 33(6):584–586. https://doi.org/10.1038/nbt.3241
Article
CAS
PubMed
Google Scholar
Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, Park A, Yang J, Suresh S, Bizhanova A, Gupta A, Bolukbasi MF, Walsh S, Bogorad RL, Gao G, Weng Z, Dong Y, Koteliansky V, Wolfe SA, Langer R, Xue W, Anderson DG (2016) Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol 34(3):328–333. https://doi.org/10.1038/nbt.3471
Article
CAS
PubMed
PubMed Central
Google Scholar
Renaud JB, Boix C, Charpentier M, De Cian A, Cochennec J, Duvernois-Berthet E, Perrouault L, Tesson L, Edouard J, Thinard R, Cherifi Y, Menoret S, Fontaniere S, de Croze N, Fraichard A, Sohm F, Anegon I, Concordet JP, Giovannangeli C (2016) Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases. Cell Rep 14(9):2263–2272. https://doi.org/10.1016/j.celrep.2016.02.018
Article
CAS
PubMed
Google Scholar